Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Open accessThe DOI matches its Crossref record; 340 of the 344 references it cites were found in a registry or an index.
Abstract
Patients with type 2 diabetes mellitus (T2DM) are at high risk for macrovascular complications, which represent the major cause of mortality. Despite effective treatment of established cardiovascular (CV) risk factors (dyslipidemia, hypertension, procoagulant state), there remains a significant amount of unexplained CV risk. Insulin resistance is associated with a cluster of cardiometabolic risk factors known collectively as the insulin resistance (metabolic) syndrome (IRS). Considerable evidence, reviewed herein, suggests that insulin resistance and the IRS contribute to this unexplained CV risk in patients with T2DM. Accordingly, CV outcome trials with pioglitazone have demonstrated that this insulin-sensitizing thiazolidinedione reduces CV events in high-risk patients with T2DM. In this review the roles of insulin resistance and the IRS in the development of atherosclerotic CV disease and the impact of the insulin-sensitizing agents and of other antihyperglycemic medications on CV outcomes are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [108]
In the citing paper
“These macrophages, in combination with adipocytes and lipid-infiltrated muscle tissues, stimulate the secretion of proinflammatory cytokines, particularly TNF-α and IL-6, while reducing the release of protective adiponectin, thereby evoking systemic chronic inflammation that directly damages the vascular endothelium and, in, turn exacerbates IR and atherosclerosis (56).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [56]
Citations
Cites
Items 201–340 of 340
Henry, R. R., Gumbiner, B., Ditzler, T., Wallace, P., Lyon, R., & Glauber, H. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.21 · Cited by 227
Insulin resistance and coronary artery disease
Bressler, P., Bailey, S. R., Matsuda, M., & DeFronzo, R. A. (1996) · Diabetologia · doi:10.1007/s001250050581 · Cited by 226
Self-citationNolan, C. J., Ruderman, N. B., Kahn, S. E., Pedersen, O., & Prentki, M. (2015) · Diabetes · doi:10.2337/db14-0694 · Cited by 226
Wong, N. D., Kouwabunpat, D., Vo, A. N., Detrano, R. C., Eisenberg, H., Goel, M., & Tobis, J. M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90133-3 · Cited by 223
Ghanim, H., Garg, R., Aljada, A., Mohanty, P., Kumbkarni, Y., Assian, E., Hamouda, W., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7309 · Cited by 218
Sinha, S., Perdomo, G., Brown, N. F., & O'Doherty, R. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406514200 · Cited by 215
Visceral adipose tissue modulates mammalian longevity
Muzumdar, R., Allison, D. B., Huffman, D. M., Ma, X., Atzmon, G., Einstein, F. H., Fishman, S., Poduval, A. D., McVei, T., Keith, S. W., et al. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00391.x · Cited by 213
Effect of insulin on growth of cultured human arterial smooth muscle cells
Pfeifle, B., & Ditschuneit, H. (1981) · Diabetologia · doi:10.1007/bf00262020 · Cited by 211
Sunder, M., Chang, A. R., & Henry, R. R. (2003) · Endocrine Practice · doi:10.4158/ep.9.5.406 · Cited by 209
Effect of Intra-arterial Insulin on Tissue Cholesterol and Fatty Acids in Alloxan-Diabetic Dogs
CRUZ, A. B., AMATUZIO, D. S., GRANDE, F., & HAY, L. J. (1961) · Circulation Research · doi:10.1161/01.res.9.1.39 · Cited by 209
Insulin signaling in the arterial wall
Hsueh, W. A., & Law, R. E. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00353-7 · Cited by 200
Thiazolidinediones improve β-cell function in type 2 diabetic patients
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2006 · Cited by 200
Self-citationGolden, S. H., Folsom, A. R., Coresh, J., Sharrett, A. R., Szklo, M., & Brancati, F. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3069 · Cited by 199
Liao, H.-W., Saver, J. L., Wu, Y.-L., Chen, T.-H., Lee, M., & Ovbiagele, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013927 · Cited by 198
Insulin resistance, insulin response, and obesity as indicators of metabolic risk
Ferrannini, E., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Nolan, J., Walker, M., Natali, A., & Beck-Nielsen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0334 · Cited by 193
Combination therapy with GLP ‐1 receptor agonist and SGLT2 inhibitor
DeFronzo, R. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12982 · Cited by 192
Self-citationGerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riddle, M. C., Rydén, L., Xavier, D., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13028 · Cited by 183
Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes
Natali, A., Baldeweg, S., Toschi, E., Capaldo, B., Barbaro, D., Gastaldelli, A., Yudkin, J. S., & Ferrannini, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1349 · Cited by 181
Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G. W., Mandarino, L. J., Shulman, G. I., & DeFronzo, R. A. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3148 · Cited by 181
Self-citationDeeg, M. A., Buse, J. B., Goldberg, R. B., Kendall, D. M., Zagar, A. J., Jacober, S. J., Khan, M. A., Perez, A. T., Tan, M. H., & on behalf of the GLAI Study Investigators (2007) · Diabetes Care · doi:10.2337/dc06-1903 · Cited by 179
Dunn, E. J., Philippou, H., Ariëns, R. A. S., & Grant, P. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0197-4 · Cited by 177
Sonesson, C., Johansson, P. A., Johnsson, E., & Gause-Nilsson, I. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0356-y · Cited by 176
Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study
Brunner, E. J., Shipley, M. J., Witte, D. R., Fuller, J. H., & Marmot, M. G. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1405 · Cited by 166
Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
Abdul-Ghani, M. A., Norton, L., & DeFronzo, R. A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00267.2015 · Cited by 165
Self-citationIozzo, P., Chareonthaitawee, P., Dutka, D., Betteridge, D. J., Ferrannini, E., & Camici, P. G. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3020 · Cited by 160
3. Foundations of Care and Comprehensive Medical Evaluation
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s006 · Cited by 159
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
Cervera, A., Wajcberg, E., Sriwijitkamol, A., Fernandez, M., Zuo, P., Triplitt, C., Musi, N., DeFronzo, R. A., & Cersosimo, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00030.2008 · Cited by 157
Self-citationLupi, R., Del Guerra, S., Marselli, L., Bugliani, M., Boggi, U., Mosca, F., Marchetti, P., & Del Prato, S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2002 · Cited by 152
Paternostro, G., Camici, P. G., Lammerstma, A. A., Marinho, N., Baliga, R. R., Kooner, J. S., Radda, G. K., & Ferrannini, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119015 · Cited by 150
Fontes-Carvalho, R., Ladeiras-Lopes, R., Bettencourt, P., Leite-Moreira, A., & Azevedo, A. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0168-x · Cited by 149
Coletta, D. K., Sriwijitkamol, A., Wajcberg, E., Tantiwong, P., Li, M., Prentki, M., Madiraju, M., Jenkinson, C. P., Cersosimo, E., Musi, N., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1256-9 · Cited by 148
Self-citationGaspari, T., Welungoda, I., Widdop, R. E., Simpson, R. W., & Dear, A. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113481817 · Cited by 148
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Lomonaco, R., Bril, F., Portillo-Sanchez, P., Ortiz-Lopez, C., Orsak, B., Biernacki, D., Lo, M., Suman, A., Weber, M. H., & Cusi, K. (2016) · Diabetes Care · doi:10.2337/dc15-1876 · Cited by 146
Sriwijitkamol, A., Christ-Roberts, C., Berria, R., Eagan, P., Pratipanawatr, T., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0677 · Cited by 145
Self-citationCardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
Abdul-Ghani, M., DeFronzo, R. A., Del Prato, S., Chilton, R., Singh, R., & Ryder, R. E. J. (2017) · Diabetes Care · doi:10.2337/dc16-2736 · Cited by 145
Self-citationMathew, M., Tay, E., & Cusi, K. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 142
Adiposity as a cause of cardiovascular disease: a Mendelian randomization study
Hagg, S., Fall, T., Ploner, A., Magi, R., Fischer, K., Draisma, H. H., Kals, M., de Vries, P. S., Dehghan, A., Willems, S. M., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv094 · Cited by 142
Role of diet and fuel overabundance in the development and progression of heart failure
Chess, D. J., & Stanley, W. C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn074 · Cited by 140
Adipokines, Insulin Resistance, and Coronary Artery Calcification
Qasim, A., Mehta, N. N., Tadesse, M. G., Wolfe, M. L., Rhodes, T., Girman, C., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.016 · Cited by 139
Ussher, J. R., Baggio, L. L., Campbell, J. E., Mulvihill, E. E., Kim, M., Kabir, M. G., Cao, X., Baranek, B. M., Stoffers, D. A., Seeley, R. J., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.009 · Cited by 139
Kashyap, S. R., Roman, L. J., Lamont, J., Masters, B. S. S., Bajaj, M., Suraamornkul, S., Belfort, R., Berria, R., Kellogg, D. L., Liu, Y., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0745 · Cited by 139
Self-citationCoronary Artery Calcification in Type 2 Diabetes and Insulin Resistance
Meigs, J. B., Larson, M. G., D’Agostino, R. B., Levy, D., Clouse, M. E., Nathan, D. M., Wilson, P. W. F., & O’Donnell, C. J. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1313 · Cited by 135
Rosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
Miyazaki, Y., He, H., Mandarino, L. J., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1943 · Cited by 135
Self-citationFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Pettiti, M., Natali, A., Mari, A., & DeFronzo, R. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1169-6 · Cited by 133
Self-citationMetabolic and molecular basis of insulin resistance
Bajaj, M., & DeFronzo, R. A. (2003) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(03)00520-8 · Cited by 131
Self-citationLiver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Yki-Järvinen, H. (2010) · Digestive Diseases · doi:10.1159/000282087 · Cited by 126
Muris, D. M. J., Houben, A. J. H. M., Schram, M. T., & Stehouwer, C. D. A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300291 · Cited by 125
Liu, Y.-F., Herschkovitz, A., Boura-Halfon, S., Ronen, D., Paz, K., LeRoith, D., & Zick, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9668-9681.2004 · Cited by 124
Sundström, J., Lind, L., Nyström, N., Zethelius, B., Andrén, B., Hales, C. N., & Lithell, H. O. (2000) · Circulation · doi:10.1161/01.cir.101.22.2595 · Cited by 123
Nonalcoholic fatty liver disease and cardiovascular risk
Misra, V. L., Khashab, M., & Chalasani, N. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0008-4 · Cited by 122
Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
Kanat, M., Mari, A., Norton, L., Winnier, D., DeFronzo, R. A., Jenkinson, C., & Abdul-Ghani, M. A. (2012) · Diabetes · doi:10.2337/db11-0995 · Cited by 122
Self-citationGolovchenko, I., Goalstone, M. L., Watson, P., Brownlee, M., & Draznin, B. (2000) · Circulation Research · doi:10.1161/01.res.87.9.746 · Cited by 121
Sironi, A. M., Pingitore, A., Ghione, S., De Marchi, D., Scattini, B., Positano, V., Muscelli, E., Ciociaro, D., Lombardi, M., Ferrannini, E., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.098640 · Cited by 121
Kern, M., Klöting, N., Mark, M., Mayoux, E., Klein, T., & Blüher, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.010 · Cited by 121
Insulin Reduces Plasma Arginase Activity in Type 2 Diabetic Patients
Kashyap, S. R., Lara, A., Zhang, R., Park, Y. M., & DeFronzo, R. A. (2008) · Diabetes Care · doi:10.2337/dc07-1198 · Cited by 120
Self-citationSasaoka, T. (1996) · Endocrinology · doi:10.1210/en.137.10.4427 · Cited by 119
Pratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118
Self-citationInsulin Resistance and Incident Heart Failure
Vardeny, O., Gupta, D. K., Claggett, B., Burke, S., Shah, A., Loehr, L., Rasmussen-Torvik, L., Selvin, E., Chang, P. P., Aguilar, D., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.07.006 · Cited by 117
Insulin secretion, insulin resistance, and obesity.
DeFronzo, R. A. (1982) · PubMed · Cited by 116
Self-citationMechanisms of Lipotoxicity in the Cardiovascular System
Wende, A. R., Symons, J. D., & Abel, E. D. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0307-2 · Cited by 110
de Rooij, S. R., Nijpels, G., Nilsson, P. M., Nolan, J. J., Gabriel, R., Bobbioni-Harsch, E., Mingrone, G., Dekker, J. M., & for the Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1795 · Cited by 109
Insulin Resistance and Risk of Incident Heart Failure: Cardiovascular Health Study
Banerjee, D., Biggs, M. L., Mercer, L., Mukamal, K., Kaplan, R., Barzilay, J., Kuller, L., Kizer, J. R., Djousse, L., Tracy, R., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000022 · Cited by 105
DeFronzo, R. A., Triplitt, C., Qu, Y., Lewis, M. S., Maggs, D., & Glass, L. C. (2010) · Diabetes Care · doi:10.2337/dc09-1521 · Cited by 104
Self-citationDeFronzo, R. A., Burant, C. F., Fleck, P., Wilson, C., Mekki, Q., & Pratley, R. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2243 · Cited by 100
Self-citationSundelin, E., Gormsen, L., Jensen, J., Vendelbo, M., Jakobsen, S., Munk, O., Christensen, M., Brøsen, K., Frøkiær, J., & Jessen, N. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.701 · Cited by 100
Lautamäki, R., Airaksinen, K. E. J., Seppänen, M., Toikka, J., Luotolahti, M., Ball, E., Borra, R., Härkönen, R., Iozzo, P., Stewart, M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2787 · Cited by 98
Chronic Endothelin-1 Treatment Leads to Insulin Resistance In Vivo
Wilkes, J. J., Hevener, A., & Olefsky, J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1904 · Cited by 98
Purnell, J. Q., Dev, R. K., Steffes, M. W., Cleary, P. A., Palmer, J. P., Hirsch, I. B., Hokanson, J. E., & Brunzell, J. D. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2623 · Cited by 97
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo
Coletta, D. K., Balas, B., Chavez, A. O., Baig, M., Abdul-Ghani, M., Kashyap, S. R., Folli, F., Tripathy, D., Mandarino, L. J., Cornell, J. E., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00607.2007 · Cited by 97
Self-citationInsulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions
Garg, R., Tripathy, D., & Dandona, P. (2003) · Current Drug Targets · doi:10.2174/1389450033490920 · Cited by 96
Kumarathurai, P., Anholm, C., Larsen, B. S., Olsen, R. H., Madsbad, S., Kristiansen, O., Nielsen, O. W., Haugaard, S. B., & Sajadieh, A. (2017) · Diabetes Care · doi:10.2337/dc16-1580 · Cited by 96
The Diabetes Prevention Program Research Group, Venditti, E. M., Bray, G. A., Carrion-Petersen, M. L., Delahanty, L. M., Edelstein, S. L., Hamman, R. F., Hoskin, M. A., Knowler, W. C., & Ma., Y. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.134 · Cited by 93
Eliasson, B., Cederholm, J., Eeg-Olofsson, K., Svensson, A.-M., Zethelius, B., Gudbjörnsdottir, S., & Register, O. B. O. T. N. D. (2011) · Diabetes Care · doi:10.2337/dc11-0209 · Cited by 93
The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
Porter, K. E., & Riches‐Suman, K. (2013) · Clinical Science · doi:10.1042/cs20120413 · Cited by 91
Eriksson, J. W., Bodegard, J., Nathanson, D., Thuresson, M., Nyström, T., & Norhammar, A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.055 · Cited by 90
Miyazaki, Y., & DeFronzo, R. A. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00880.x · Cited by 89
Self-citationSheu, W. H., Shieh, S. M., Fuh, M. M., Shen, D. D., Jeng, C. Y., Chen, Y. D., & Reaven, G. M. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.367 · Cited by 88
Dormandy, J., Betteridge, D. J., Schernthaner, G., Pīrāgs, V., & Norgren, L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.002 · Cited by 87
Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
Bajaj, M., Baig, R., Suraamornkul, S., Hardies, L. J., Coletta, D. K., Cline, G. W., Monroy, A., Koul, S., Sriwijitkamol, A., Musi, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0911 · Cited by 84
Self-citationTokudome, T., Horio, T., Yoshihara, F., Suga, S., Kawano, Y., Kohno, M., & Kangawa, K. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.006 · Cited by 82
Derosa, G., D'Angelo, A., Ragonesi, P. D., Ciccarelli, L., Piccinni, M. N., Pricolo, F., Salvadeo, S. A. T., Montagna, L., Gravina, A., Ferrari, I., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00756.x · Cited by 82
on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
Chronic insulin administration elevates blood pressure in rats.
Meehan, W. P., Buchanan, T. A., & Hsueh, W. A. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1012 · Cited by 79
Effect of Insulin in the Induction and Regression of Atherosclerosis in the Chick
Stamler, J., Pick, R. L., & Katz, L. N. (1960) · Circulation Research · doi:10.1161/01.res.8.3.572 · Cited by 78
Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure
Arturi, F., Succurro, E., Miceli, S., Cloro, C., Ruffo, M., Maio, R., Perticone, M., Sesti, G., & Perticone, F. (2016) · Endocrine · doi:10.1007/s12020-016-1166-4 · Cited by 78
Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors
Fall, T., Hägg, S., Ploner, A., Mägi, R., Fischer, K., Draisma, H. H. M., Sarin, A.-P., Benyamin, B., Ladenvall, C., Åkerlund, M., et al. (2015) · Diabetes · doi:10.2337/db14-0988 · Cited by 73
Lindsey, J. B., House, J. A., Kennedy, K. F., & Marso, S. P. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.876672 · Cited by 72
Insulin Sensitivity and Albuminuria: The RISC Study
Pilz, S., Rutters, F., Nijpels, G., Stehouwer, C. D. A., Højlund, K., Nolan, J. J., Balkau, B., Dekker, J. M., & the RISC Investigators (2014) · Diabetes Care · doi:10.2337/dc13-2573 · Cited by 72
Sarwar, N., Sattar, N., Gudnason, V., & Danesh, J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm115 · Cited by 70
Bhatt, B. A., Dube, J. J., Dedousis, N., Reider, J. A., & O’Doherty, R. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00097.2005 · Cited by 69
Metabolic syndrome: Evaluation of pathological and therapeutic outcomes
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.012 · Cited by 68
Self-citationInsulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Scherer, T., Lindtner, C., O’Hare, J., Hackl, M., Zielinski, E., Freudenthaler, A., Baumgartner-Parzer, S., Tödter, K., Heeren, J., Krššák, M., et al. (2016) · Diabetes · doi:10.2337/db15-1552 · Cited by 66
Pleiotropic effects of thiazolidinediones
Rizos, C., Liberopoulos, E., Mikhailidis, D., & Elisaf, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1087 · Cited by 65
Insulin Resistance, Hypertension, and Coronary Heart Disease
Reaven, G. M. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.01764.x · Cited by 63
Dietary polyunsaturated fatty acids and composition of human aortic plaques
Felton, C. V., Crook, D., Davies, M. J., & Oliver, M. F. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90511-8 · Cited by 63
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes
Clarke, G. D., Solis-Herrera, C., Molina-Wilkins, M., Martinez, S., Merovci, A., Cersosimo, E., Chilton, R. J., Iozzo, P., Gastaldelli, A., Abdul-Ghani, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0078 · Cited by 63
Self-citationAbdul-Ghani, M., & DeFronzo, R. A. (2017) · Diabetes Care · doi:10.2337/dc16-2368 · Cited by 62
Self-citationHyperinsulinemia Potentiates Activation of p21Ras by Growth Factors
Leitner, J. W., Kline, T., Carel, K., Goalstone, M., & Draznin, B. (1997) · Endocrinology · doi:10.1210/endo.138.5.5240 · Cited by 61
Solis-Herrera, C., Triplitt, C., Garduno-Garcia, J. D. J., Adams, J., DeFronzo, R. A., & Cersosimo, E. (2013) · Diabetes Care · doi:10.2337/dc12-2072 · Cited by 60
Self-citationYamazoe, M., Hisamatsu, T., Miura, K., Kadowaki, S., Zaid, M., Kadota, A., Torii, S., Miyazawa, I., Fujiyoshi, A., Arima, H., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307612 · Cited by 59
Iozzo, P., Pratipanawatr, T., Pijl, H., Vogt, C., Kumar, V., Pipek, R., Matsuda, M., Mandarino, L. J., Cusi, K. J., & DeFronzo, R. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e712 · Cited by 57
Self-citationShort-Term Hyperinsulinemia and Hyperglycemia Increase Myocardial Lipid Content in Normal Subjects
Winhofer, Y., Krššák, M., Janković, D., Anderwald, C.-H., Reiter, G., Hofer, A., Trattnig, S., Luger, A., & Krebs, M. (2012) · Diabetes · doi:10.2337/db11-1275 · Cited by 56
Kozàkovà, M., Natali, A., Dekker, J., Beck‐Nielsen, H., Laakso, M., Nilsson, P. M., Balkau, B., & Ferrannini, E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300948 · Cited by 56
Hirano, T., & Mori, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12446 · Cited by 55
Nakao, J., Ito, H., Kanayasu, T., & Murota, S. (1985) · Diabetes · doi:10.2337/diab.34.2.185 · Cited by 54
Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study
Britton, K. A., Mukamal, K. J., Ix, J. H., Siscovick, D. S., Newman, A. B., de Boer, I. H., Thacker, E. L., Biggs, M. L., Gaziano, J. M., & Djoussé, L. (2012) · Vascular Medicine · doi:10.1177/1358863x11436195 · Cited by 53
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
"Normal" insulin secretion: the goal of artificial insulin delivery systems?
Rp, E., ALLEN, R. M., Schade, D. S., & Standefer, J. C. (1980) · PubMed · Cited by 50
Di Pino, A., Urbano, F., Zagami, R. M., Filippello, A., Di Mauro, S., Piro, S., Purrello, F., & Rabuazzo, A. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4069 · Cited by 50
Koopmans, S. J., Kushwaha, R. S., & DeFronzo, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90081-1 · Cited by 48
Self-citationRana, J. S., Visser, M. E., Arsenault, B. J., Després, J., Stroes, E. S. G., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.123 · Cited by 48
Fakhrzadeh, H., Sharifi, F., Alizadeh-Khoei, M., Arzaghi, S. M., Tajalizadekhoob, Y., Tootee, A., Alatab, S., Mirarefin, M., Badamchizade, Z., & Kazemi, H. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0263-5 · Cited by 48
Rosiglitazone treatment increases nitric oxide production in human peripheral skin
Vinik, A. I., Stansberry, K. B., & Barlow, P. M. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00006-0 · Cited by 46
Smits, M. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Diamant, M., van Raalte, D. H., & Serné, E. H. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305447 · Cited by 44
Sartori, M., Ceolotto, G., Papparella, I., Baritono, E., Ciccariello, L., Calò, L., Leoni, M., & Semplicini, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.017 · Cited by 42
von Bibra, H., Paulus, W. J., Sutton, M. S. J., Leclerque, C., Schuster, T., & Schumm‐Draeger, P. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.005 · Cited by 40
Dietary trans fatty acids and composition of human atheromatous plaques
Stachowska, E., Dołęgowska, B., Chlubek, D., Wesołowska, T., Ciechanowski, K., Gutowski, P., Szumiłowicz, H., & Turowski, R. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0479-x · Cited by 40
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit
Ryder, R. E. J. (2014) · Diabetic Medicine · doi:10.1111/dme.12627 · Cited by 39
“Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?
Eaton, R. P., Allen, R. C., Schade, D. S., & Standefer, J. C. (1980) · Diabetes Care · doi:10.2337/diacare.3.2.270 · Cited by 39
Qin, S., Liu, T., Kamanna, V. S., & Kashyap, M. L. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150193 · Cited by 38
Yoshida, M., Takamatsu, J., Yoshida, S., Tanaka, K., Takeda, K., Higashi, H., Kitaoka, H., & Ohsawa, N. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978795 · Cited by 36
Bertrand, O. F., Poirier, P., Rodés‐Cabau, J., Rinfret, S., Title, L. M., Džavík, V., Natarajan, M. K., Angel, J. G. D., Batalla, N., Alméras, N., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.005 · Cited by 34
Cersósimo, E., Xu, X., & Musi, N. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00022.2011 · Cited by 34
Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension
Liu, L., Liu, J., & Huang, Y. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000176 · Cited by 32
Strongman, H., Christopher, S., Majak, M., Williams, R., Bahmanyar, S., Linder, M., Heintjes, E. M., Bennett, D., Korhonen, P. A., & Hoti, F. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000481 · Cited by 32
Stout, R. W. (1971) · Diabetologia · doi:10.1007/bf01219472 · Cited by 31
Calanna, S., Urbano, F., Piro, S., Zagami, R. M., Pino, A. D., Spadaro, L., Purrello, F., & Rabuazzo, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0765 · Cited by 29
Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α
Lucero, D., Miksztowicz, V., Macri, E. V., López, G. H., Friedman, S., Berg, G. A., Zago, V., & Schreier, L. E. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.11.002 · Cited by 29
Eriksson, L., Saxelin, R., Röhl, S., Roy, J., Caidahl, K., Nyström, T., Hedin, U., & Razuvaev, A. (2015) · Journal of Vascular Research · doi:10.1159/000381097 · Cited by 27
Insulin sensitivity in familial hypercholesterolemia
Galvan, A. Q., Santoro, D., Natali, A., Sampietro, T., Boni, C. D., Masoni, A., Buzzigoli, G., & Ferrannini, E. (1993) · Metabolism · doi:10.1016/0026-0495(93)90138-e · Cited by 26
Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials
Stojanović, M., Prostran, M. S., & Radenković, M. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1999-4 · Cited by 26
Pérez-Girón, J. V., Palacios, R., Martín, Á., Hernanz, R., Aguado, A., Martínez‐Revelles, S., Barrús, M. T., Salaíces, M., & Alonso, M. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00924.2013 · Cited by 25
Lu, Y., Ma, D., Xu, W., Shao, S., & Yu, X. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12246 · Cited by 25
Rosiglitazone treatment and cardiovascular disease in the V eterans A ffairs D iabetes Trial
Florez, H. J., Reaven, P. D., Bahn, G., MORITZ, T. E., Warren, S., Marks, J., Reda, D. J., Duckworth, W. C., Abraira, C., Hayward, R. A., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12487 · Cited by 21
Does Insulin Resistance Drive the Association between Hyperglycemia and Cardiovascular Risk?
Færch, K., Bergman, B. C., & Perreault, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039260 · Cited by 20
Relationship between simple markers of insulin resistance and coronary artery calcification
Reaven, G. M., Knowles, J. W., Leonard, D. S., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.013 · Cited by 20
Nathanson, D., Frick, M., Ullman, B., & Nyström, T. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0116-2 · Cited by 19
Euglycemic Clamp Insulin Sensitivity and Longitudinal Systolic Blood Pressure
Petrie, J. R., Malik, M. O., Balkau, B., Perry, C. G., Højlund, K., Pataky, Z., Nolan, J. J., Ferrannini, E., & Natali, A. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00439 · Cited by 17
Relationship between Insulin Resistance and Coronary Artery Calcium in Young Men and Women
Sung, K., Choi, J., Gwon, H., Choi, S., Kim, B., Kwag, H. J., & Kim, S. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053316 · Cited by 14
Insulin resistance, hypertension and cellular ion transport systems
Solini, A., & DeFronzo, R. A. (1992) · Acta Diabetologica · doi:10.1007/bf00573488 · Cited by 6
Self-citation
Research works printed but not linked: 1
- Hsueh, 1999, Insulin signals in the arterial wall, J Cardiol, 84, 21, 10.1016/S0002-9149(99)00353-7 · DOI · Paper page
Cited by
Ding, X., Wang, X., Wu, J., Zhang, M., & Cui, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01268-9 · Cited by 454
“Pathophysiologically, the current results reflect the previously suggested role of insulin resistance in the pathogenesis of atherosclerosis [8, 10].”
BackgroundInsulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“MAPK Family JNK is a member of the MAPK family and is activated by TNF-α, IL-1β, free-fatty acids, ER stress, and LTB4 [66,67].”
BackgroundInfluentialHong, S., Han, K., & Park, C.-Y. (2020) · BMC Medicine · doi:10.1186/s12916-020-01824-2 · Cited by 376
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
Metadata
- Authors
- Di Pino, A., & DeFronzo, R. A.
- Affiliations
- Diabetes Division, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- DeFronzo, Ralph A
- ORCID
- DeFronzo, Ralph A
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-05-03
- Volume
- 40
- Issue
- 6
- Pages
- 1447-1467
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7445419
- OpenAlex
- W2945554427
- Cited by
- 535
- References
- 344
- Citations by year
- 2026: 77 · 2025: 117 · 2024: 95 · 2023: 76 · 2022: 89 · 2021: 55 · 2020: 22 · 2019: 4
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-24092-38)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, atherosclerosis, type 2 diabetes, metabolic syndrome, insulin sensitizers, thiazolidinediones, pioglitazone, cardiovascular risk, macrovascular complications, cardiovascular outcome trials, antihyperglycemic medications, cardiometabolic risk factors
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin Resistance, Thiazolidinediones, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.